Skip to main content

Clostridium perfringens Epsilon Toxin: Structural and Mechanistic Insights

  • Living reference work entry
  • First Online:

Part of the book series: Toxinology ((TOXI))

Abstract

Epsilon toxin (ETX) is produced by strains of Clostridium perfringens classified as type B or D. ETX belongs to the heptameric β-pore-forming toxins including Aeromonas aerolysin and Clostridium septicum alpha toxin, which are characterized by the formation of a pore through the plasma membrane of eukaryotic cells and containing a β-barrel composed of 14 amphipathic β-strands. In contrast to aerolysin and C. septicum alpha toxin, ETX is a much more potent toxin, which is responsible for enterotoxemia in animals, mainly in sheep. ETX induces perivascular edema in various tissues and accumulates particularly in the kidneys and in the brain, where it causes edema and necrotic lesions. ETX is able to pass through the blood-brain barrier (BBB) and to stimulate the release of glutamate, which accounts for the nervous excitation symptoms observed in animal enterotoxemia. At the cellular level, ETX causes a rapid swelling followed by a cell death involving necrosis. Recently, ETX has been found to induce demyelination and could be involved in demyelinating diseases like multiple sclerosis. The precise mode of action of ETX remains undetermined.

This is a preview of subscription content, log in via an institution.

References

  • Banks WA. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol. 2009;9 Suppl 1:S3.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bokori-Brown M, Kokkinidou MC, Savva CG, Fernandes da Costa S, Naylor CE, Cole AR, Moss DS, Basak AK, Titball RW. Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies. Protein Sci. 2013;22(5):650–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bokori-Brown M, Hall CA, Vance C, Fernandes da Costa SP, Savva CG, Naylor CE, Cole AR, Basak AK, Moss DS, Titball RW. Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia. Vaccine. 2014;32(23):2682–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Borrmann E, Günther H, Köhler H. Effect of Clostridium perfringens epsilon toxin on MDCK cells. FEMS Immunol Med Microbiol. 2001;31:85–92.

    Article  CAS  PubMed  Google Scholar 

  • Briggs DC, Naylor CE, Smedley 3rd JG, Lukoyanova N, Robertson S, Moss DS, McClane BA, Basak AK. Structure of the food-poisoning Clostridium perfringens enterotoxin reveals similarity to the aerolysin-like pore-forming toxins. J Mol Biol. 2011;413(1):138–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Buxton D, Morgan KT. Studies of lesions produced in the brains of colostrum deprived lambs by Clostridium welchii (Cl. perfringens) type D toxin. J Comp Pathol. 1976;86(3):435–47.

    Article  CAS  PubMed  Google Scholar 

  • Chassin C, Bens M, de Barry J, Courjaret R, Bossu JL, Cluzeaud F, Ben Mkaddem S, Gibert M, Poulain B, Popoff MR, Vandewalle A. Pore-forming epsilon toxin causes membrane permeabilization and rapid ATP depletion-mediated cell death in renal collecting duct cells. Am J Physiol Renal Physiol. 2007;293(3):F927–37.

    Article  CAS  PubMed  Google Scholar 

  • Chen J, McClane BA. Role of the agr-like quorum sensing system in regulating toxin production by Clostridium perfringens type B strains CN1793 and CN1795. Infect Immun. 2012;80:3008–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cole AR, Gibert M, Popoff MR, Moss DS, Titball RW, Basak A. Clostridium perfringens ε-toxin shows structural similarity to the pore-forming toxin aerolysin. Nat Struct Mol Biol. 2004;11:797–8.

    Article  CAS  PubMed  Google Scholar 

  • Degiacomi MT, Iacovache I, Pernot L, Chami M, Kudryashev M, Stahlberg H, van der Goot FG, Dal Peraro M. Molecular assembly of the aerolysin pore reveals a swirling membrane-insertion mechanism. Nat Chem Biol. 2013;9(10):623–9.

    Article  CAS  PubMed  Google Scholar 

  • Dorca-Arevalo J, Soler-Jover A, Gibert M, Popoff MR, Martin-Satue M, Blasi J. Binding of epsilon-toxin from Clostridium perfringens in the nervous system. Vet Microbiol. 2008;131(1–2):14–25.

    Article  CAS  PubMed  Google Scholar 

  • Dorca-Arevalo J, Martin-Satue M, Blasi J. Characterization of the high affinity binding of epsilon toxin from Clostridium perfringens to the renal system. Vet Microbiol. 2012;157:179–89.

    Article  CAS  PubMed  Google Scholar 

  • Fennessey CM, Ivie SE, McClain MS. Coenzyme depletion by members of the aerolysin family of pore-forming toxins leads to diminished ATP levels and cell death. Mol Biosyst. 2012a;8(8):2097–105.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fennessey CM, Sheng J, Rubin DH, McClain MS. Oligomerization of Clostridium perfringens epsilon toxin is dependent upon caveolins 1 and 2. PLoS One. 2012b;7(10):e46866.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fernandez Miyakawa ME, Uzal FA. The early effects of Clostridium perfringens type D epsilon toxin in ligated intestinal loops of goats and sheep. Vet Res Commun. 2003;27(3):231–41.

    Article  CAS  PubMed  Google Scholar 

  • Fernandez Miyakawa ME, Zabal O, Silberstein C. Clostridium perfringens epsilon toxin is cytotoxic for human renal tubular epithelial cells. Hum Exp Toxicol. 2011;30:275–82.

    Article  CAS  PubMed  Google Scholar 

  • Ferrarezi MC, Curci VC, Cardoso TC. Cellular vacuolation and mitochondrial-associated factors induced by Clostridium perfringens epsilon toxin detected using acoustic flow cytometry. Anaerobe. 2013;24:55–9.

    Article  CAS  PubMed  Google Scholar 

  • Finnie JW. Histopathological changes in the brain of mice given Clostridium perfringens type D epsilon toxin. J Comp Pathol. 1984a;94(3):363–70.

    Article  CAS  PubMed  Google Scholar 

  • Finnie JW. Ultrastructural changes in the brain of mice given Clostridium perfringens type D epsilon toxin. J Comp Pathol. 1984b;94(3):445–52.

    Article  CAS  PubMed  Google Scholar 

  • Finnie JW. Neurological disorders produced by Clostridium perfringens type D epsilon toxin. Anaerobe. 2004;10(2):145–50.

    Article  CAS  PubMed  Google Scholar 

  • Finnie JW, Blumbergs PC, Manavis J. Neuronal damage produced in rat brains by Clostridium perfringens type D epsilon toxin. J Comp Pathol. 1999;120(4):415–20.

    Article  CAS  PubMed  Google Scholar 

  • Garcia JP, Adams V, Beingesser J, Hughes ML, Poon R, Lyras D, Hill A, McClane BA, Rood JI, Uzal FA. Epsilon toxin is essential for the virulence of Clostridium perfringens type D infection in sheep, goats, and mice. Infect Immun. 2013;81(7):2405–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Garcia JP, Beingesser J, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly M, Velasco J, Whaley K, Zeitlin L, Roy CJ, Uzal FA. Prevention and treatment of Clostridium perfringens epsilon toxin intoxication in mice with a neutralizing monoclonal antibody (c4D7) produced in Nicotiana benthamiana. Toxicon. 2014;88:93–8.

    Article  CAS  PubMed  Google Scholar 

  • Geny B, Popoff MR. Bacterial protein toxins and lipids: pore formation or toxin entry into cells. Biol Cell. 2006;98:667–78.

    Article  CAS  PubMed  Google Scholar 

  • Gil C, Dorca-Arevalo J, Blasi J. Clostridium perfringens epsilon toxin binds to membrane lipids and its cytotoxic action depends on sulfatide. PLoS One. 2015;10(10):e0140321.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gill DM. Bacterial toxins: lethal amounts. In: Laskin AI, Lechevalier HA, editors. Toxins and enzymes, vol. 8. Cleveland: CRC Press; 1987. p. 127–35.

    Google Scholar 

  • Gordon VM, Nelson KL, Buckley JT, Stevens VL, Tweten RK, Elwood PC, Leppla SH. Clostridium septicum alpha-toxin uses glycosylphosphatidylinositol-anchored protein receptors. J Biol Chem. 1999;274:27274–80.

    Article  CAS  PubMed  Google Scholar 

  • Gurjar A, Li J, McClane BA. Characterization of toxin plasmids in Clostridium perfringens type C isolates. Infect Immun. 2010;78(11):4860–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hirschberg H, Zhang MJ, Gach HM, Uzal FA, Peng Q, Sun CH, Chighvinadze D, Madsen SJ. Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin. J Neurooncol. 2009;95:317–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hunter SE, Clarke IN, Kelly DC, Titball RW. Cloning and nucleotide sequencing of the Clostridium perfringens epsilon-toxin gene and its expression in Escherichia coli. Infect Immun. 1992;60:102–10.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ivie SE, Fennessey CM, Sheng J, Rubin DH, McClain MS. Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens epsilon-toxin. PLoS One. 2011;6(3):e17787.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Justin N, Walker N, Bullifent HL, Songer G, Bueschel DM, Jost H, Naylor C, Miller J, Moss DS, Titball RW, Basak AK. The first strain of Clostridium perfringens isolated from an avian source has an alpha-toxin with divergent structural and kinetics properties. Biochemistry. 2002;41:6253–62.

    Article  CAS  PubMed  Google Scholar 

  • Kitadokoro K, Nishimura K, Kamitani S, Fukui-Miyazaki A, Toshima H, Abe H, Kamata Y, Sugita-Konishi Y, Yamamoto S, Karatani H, Horiguchi Y. Crystal structure of Clostridium perfringens enterotoxin displays features of beta-pore-forming toxins. J Biol Chem. 2011;286(22):19549–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Knapp O, Maier E, Benz R, Geny B, Popoff MR. Identification of the channel-forming domain of Clostridium perfringens epsilon-toxin (ETX). Biochim Biophys Acta. 2009;1788(12):2584–93.

    Article  CAS  PubMed  Google Scholar 

  • Knapp O, Maier E, Mkaddem SB, Benz R, Bens M, Chenal A, Geny B, Vandewalle A, Popoff MR. Clostridium septicum alpha-toxin forms pores and induces rapid cell necrosis. Toxicon. 2010a;55(1):61–72.

    Article  CAS  PubMed  Google Scholar 

  • Knapp O, Stiles BG, Popoff MR. The aerolysin-like toxin family of cytolytic, pore-forming toxins. Open Toxinol J. 2010b;3:53–68.

    Article  CAS  Google Scholar 

  • Lewis M, Weaver CD, McClain MS. Identification of small molecule inhibitors of Clostridium perfringens epsilon-toxin cytotoxicity using a cell-based high-throughput screen. Toxins (Basel). 2010;2(7):1825–47.

    Article  CAS  Google Scholar 

  • Li Q, Xin W, Gao S, Kang L, Wang J. A low-toxic site-directed mutant of Clostridium perfringens epsilon-toxin as a potential candidate vaccine against enterotoxemia. Hum Vaccines Immunother. 2013;9(11):2386–92.

    Article  CAS  Google Scholar 

  • Li J, Freedman JC, McClane BA. NanI Sialidase, CcpA, and CodY work together to regulate epsilon toxin production by Clostridium perfringens type D strain CN3718. J Bacteriol. 2015;197(20):3339–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Linden JR, Ma Y, Zhao B, Harris JM, Rumah KR, Schaeren-Wiemers N, Vartanian T. Clostridium perfringens epsilon toxin causes selective death of mature oligodendrocytes and central nervous system demyelination. MBio. 2015;6(3):e02513.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lindsay CD, Hambrook JL, Upshall DG. Examination of toxicity of Clostridium perfringens ε-toxin in the MDCK cell line. Toxicol In Vitro. 1995;9:213–8.

    Article  CAS  PubMed  Google Scholar 

  • Lobato FC, Lima CG, Assis RA, Pires PS, Silva RO, Salvarani FM, Carmo AO, Contigli C, Kalapothakis E. Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants. Vaccine. 2010;28(38):6125–7.

    Article  CAS  PubMed  Google Scholar 

  • Lonchamp E, Dupont JL, Wioland L, Courjaret R, Mbebi-Liegeois C, Jover E, Doussau F, Popoff MR, Bossu JL, de Barry J, Poulain B. Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release. PLoS One. 2010;5(9):e13046.

    Article  PubMed  PubMed Central  Google Scholar 

  • Manni MM, Sot J, Goni FM. Interaction of Clostridium perfringens epsilon-toxin with biological and model membranes: a putative protein receptor in cells. Biochim Biophys Acta. 2015;1848(3):797–804.

    Article  CAS  PubMed  Google Scholar 

  • Mantis NJ. Vaccines against the category B toxins: Staphylococcal enterotoxin B, epsilon toxin and ricin. Adv Drug Deliv Rev. 2005;57(9):1424–39.

    Article  CAS  PubMed  Google Scholar 

  • Masson JB, Casanova D, Turkcan S, Voisinne G, Popoff MR, Vergassola M, Alexandrou A. Inferring maps of forces inside cell membrane microdomains. Phys Rev Lett. 2009;102(4):048103.

    Article  PubMed  Google Scholar 

  • Mathur DD, Deshmukh S, Kaushik H, Garg LC. Functional and structural characterization of soluble recombinant epsilon toxin of Clostridium perfringens D, causative agent of enterotoxaemia. Appl Microbiol Biotechnol. 2010;88(4):877–84.

    Article  CAS  PubMed  Google Scholar 

  • Matute C. Glutamate and ATP signalling in white matter pathology. J Anat. 2011;219(1):53–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Matute C, Domercq M, Sanchez-Gomez MV. Glutamate-mediated glial injury: mechanisms and clinical importance. Glia. 2006;53(2):212–24.

    Article  PubMed  Google Scholar 

  • McClain MS, Cover TL. Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin. Infect Immun. 2007;75(4):1785–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Melton JA, Parker MW, Rossjohn J, Buckley JT, Tweten RK. The identification and structure of the membrane-spanning domain of the Clostridium septicum alpha toxin. J Biol Chem. 2004;279(14):14315–22.

    Article  CAS  PubMed  Google Scholar 

  • Minami J, Katayama S, Matsushita O, Matsushita C, Okabe A. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides. Microbiol Immunol. 1997;41:527–35.

    Article  CAS  PubMed  Google Scholar 

  • Miyamoto O, Minami J, Toyoshima T, Nakamura T, Masada T, Nagao S, Negi T, Itano T, Okabe A. Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via glutamanergic system. Infect Immun. 1998;66:2501–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Miyamoto O, Sumitami K, Nakamura T, Yamagani S, Miyatal S, Itano T, Negi T, Okabe A. Clostridium perfringens epsilon toxin causes excessive release of glutamate in the mouse hippocampus. FEMS Microbiol Lett. 2000;189:109–13.

    Article  CAS  PubMed  Google Scholar 

  • Miyata S, Matsushita O, Minami J, Katayama S, Shimamoto S, Okabe A. Cleavage of C-terminal peptide is essential for heptamerization of Clostridium perfringens ε-toxin in the synaptosomal membrane. J Biol Chem. 2001;276:13778–83.

    Article  CAS  PubMed  Google Scholar 

  • Miyata S, Minami J, Tamai E, Matsushita O, Shimamoto S, Okabe A. Clostridium perfringens ε-toxin forms a heptameric pore within the detergent-insoluble microdomains of Madin-Darby Canine Kidney Cells and rat synaptosomes. J Biol Chem. 2002;277:39463–8.

    Article  CAS  PubMed  Google Scholar 

  • Mollby R, Holme T, Nord CE, Smyth CJ, Wadstrom T. Production of phospholipase C (alpha-toxin), haemolysins and lethal toxins by Clostridium perfringens types A to D. J Gen Microbiol. 1976;96(1):137–44.

    Article  CAS  PubMed  Google Scholar 

  • Murrel TGC, O’Donoghue PJ, Ellis T. A review of the sheep-multiple sclerosis connection. Med Hypotheses. 1986;19:27–39.

    Article  Google Scholar 

  • Nagahama M, Sakurai J. Distribution of labeled Clostridium perfringens epsilon toxin in mice. Toxicon. 1991;29(2):211–7.

    Article  CAS  PubMed  Google Scholar 

  • Nagahama M, Sakurai J. High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain. Infect Immun. 1992;60(3):1237–40.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Nagahama M, Hara H, Fernandez-Miyakawa M, Itohayashi Y, Sakurai J. Oligomerization of Clostridium perfringens epsilon-toxin is dependent upon membrane fluidity in liposomes. Biochemistry. 2006;45(1):296–302.

    Article  CAS  PubMed  Google Scholar 

  • Nagahama M, Itohayashi Y, Hara H, Higashihara M, Fukatani Y, Takagishi T, Oda M, Kobayashi K, Nakagawa I, Sakurai J. Cellular vacuolation induced by Clostridium perfringens epsilon-toxin. Febs J. 2011;278(18):3395–407.

    Article  CAS  PubMed  Google Scholar 

  • Nestorovich EM, Karginov VA, Bezrukov SM. Polymer partitioning and ion selectivity suggest asymmetrical shape for the membrane pore formed by epsilon toxin. Biophys J. 2010;99(3):782–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Odendaal MW, Visser JJ, Bergh N, Botha WJ. The effect of passive immunization on active immunity against Clostridium perfringens type D in lambs. Onderstepoort J Vet Res. 1989;56(4):251–5.

    CAS  PubMed  Google Scholar 

  • Oyston PCF, Payne DW, Havard HL, Williamson ED, Titball RW. Production of a non-toxic site-directed mutant of Clostridium perfringens e-toxin which induces protective immunity in mice. Microbiology. 1998;144:333–41.

    Article  CAS  PubMed  Google Scholar 

  • Parker MW, Buckley JT, Postma JP, Tucker AD, Leonard K, Pattus F, Tsernoglou D. Structure of the Aeromonas toxin proaerolysin in its water-soluble and membrane-channel states. Nature. 1994;367(6460):292–5.

    Article  CAS  PubMed  Google Scholar 

  • Payne DW, Williamson ED, Havard H, Modi N, Brown J. Evaluation of a new cytotoxicity assay for Clostridium perfringens type D epsilon toxin. FEMS Microbiol Lett. 1994;116:161–8.

    Article  CAS  PubMed  Google Scholar 

  • Pelish TM, McClain MS. Dominant-negative inhibitors of the Clostridium perfringens epsilon-toxin. J Biol Chem. 2009;284(43):29446–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petit L, Gibert M, Gillet D, Laurent-Winter C, Boquet P, Popoff MR. Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex. J Bacteriol. 1997;179:6480–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Petit L, Gibert M, Popoff MR. Clostridium perfringens: toxinotype and genotype. Trends Microbiol. 1999;7:104–10.

    Article  CAS  PubMed  Google Scholar 

  • Petit L, Maier E, Gibert M, Popoff MR, Benz R. Clostridium perfringens epsilon-toxin induces a rapid change in cell membrane permeability to ions and forms channels in artificial lipid bilayers. J Biol Chem. 2001;276:15736–40.

    Article  CAS  PubMed  Google Scholar 

  • Petit L, Gibert M, Gourch A, Bens M, Vandewalle A, Popoff MR. Clostridium perfringens Epsilon Toxin rapidly decreases membrane barrier permeability of polarized MDCK Cells. Cell Microbiol. 2003;5:155–64.

    Article  CAS  PubMed  Google Scholar 

  • Popoff MR, Bouvet P. Clostridial toxins. Future Microbiol. 2009;4:1021–64.

    Article  CAS  PubMed  Google Scholar 

  • Popoff MR, Bouvet P. Genetic characteristics of toxigenic Clostridia and toxin gene evolution. Toxicon. 2013;75(g):63–89.

    Article  CAS  PubMed  Google Scholar 

  • Robertson SL, Li J, Uzal FA, McClane BA. Evidence for a prepore stage in the action of Clostridium perfringens epsilon toxin. PLoS One. 2011;6(7):e22053.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rood JI. Virulence genes of Clostridium perfringens. Annu Rev Microbiol. 1998;52:333–60.

    Article  CAS  PubMed  Google Scholar 

  • Rumah KR, Linden J, Fischetti VA, Vartanian T. Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease. PLoS One. 2013;8(10):e76359.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rumah KR, Ma Y, Linden JR, Oo ML, Anrather J, Schaeren-Wiemers N, Alonso MA, Fischetti VA, McClain MS, Vartanian T. The myelin and lymphocyte protein MAL is required for binding and activity of Clostridium perfringens epsilon-toxin. PLoS Pathog. 2015;11(5):e1004896.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sakurai J. Toxins of Clostridium perfringens. Rev Med Microbiol. 1995;6:175–85.

    Google Scholar 

  • Sayeed S, Li J, McClane BA. Virulence plasmid diversity in Clostridium perfringens type D isolates. Infect Immun. 2007;75(5):2391–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schaeren-Wiemers N, Valenzuela DM, Frank M, Schwab ME. Characterization of a rat gene, rMAL, encoding a protein with four hydrophobic domains in central and peripheral myelin. J Neurosci. 1995;15(8):5753–64.

    CAS  PubMed  Google Scholar 

  • Schleberger C, Hochmann H, Barth H, Aktories K, Schulz GE. Structure and action of the binary C2 toxin from Clostridium botulinum. J Mol Biol. 2006;364:705–15.

    Article  CAS  PubMed  Google Scholar 

  • Shortt SJ, Titball RW, Lindsay CD. An assessment of the in vitro toxicology of Clostridium perfringens type D epsilon-toxin in human and animal cells. Hum Exp Toxicol. 2000;19(2):108–16.

    Article  CAS  PubMed  Google Scholar 

  • Slemmer JE, De Zeeuw CI, Weber JT. Don’t get too excited: mechanisms of glutamate-mediated Purkinje cell death. Prog Brain Res. 2005;148:367–90.

    Article  CAS  PubMed  Google Scholar 

  • Soler-Jover A, Dorca J, Popoff MR, Gibert M, Saura J, Tusell JM, Serratosa J, Blasi J, Martin-Satue M. Distribution of Clostridium perfringens epsilon toxin in the brains of acutely intoxicated mice and its effect upon glial cells. Toxicon. 2007;50(4):530–40.

    Article  CAS  PubMed  Google Scholar 

  • Sully EK, Whaley K, Bohorova N, Bohorov O, Goodman C, Kim D, Pauly M, Velasco J, Holtsberg FW, Stavale E, Aman MJ, Tangudu C, Uzal FA, Mantis NJ, Zeitlin L. A tripartite cocktail of chimeric monoclonal antibodies passively protects mice against ricin, staphylococcal enterotoxin B and Clostridium perfringens epsilon toxin. Toxicon. 2014;92:36–41.

    Article  CAS  PubMed  Google Scholar 

  • Titball RW. Clostridium perfringens vaccines. Vaccine. 2009;27 Suppl 4:D44–7.

    Article  CAS  PubMed  Google Scholar 

  • Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci. 2008;31:247–69. doi:10.1146/annurev.neuro.1130.051606.094313.

    Article  CAS  PubMed  Google Scholar 

  • Tsutsui K, Minami J, Matsushita O, Katayama S, Taniguchi Y, Nakamura S, Nishioka M, Okabe A. Phylogenetic analysis of phospholipase C genes from Clostridium perfringens types A to E and Clostridium novyi. J Bacteriol. 1995;177:7164–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Turkcan S, Masson JB, Casanova D, Mialon G, Gacoin T, Boilot JP, Popoff MR, Alexandrou A. Observing the confinement potential of bacterial pore-forming toxin receptors inside rafts with nonblinking eu(3+)-doped oxide nanoparticles. Biophys J. 2012;102(10):2299–308.

    Google Scholar 

  • Turkcan S, Richly MU, Alexandrou A, Masson JB. Probing membrane protein interactions with their lipid raft environment using single-molecule tracking and Bayesian inference analysis. PLoS One. 2013a;8(1):e53073. doi: 10.1371/journal.pone.0053073.

    Google Scholar 

  • Turkcan S, Richly MU, Bouzigues CI, Allain JM, Alexandrou A. Receptor displacement in the cell membrane by hydrodynamic force amplification through nanoparticles. Biophys J. 2013b;105(1):116–26. doi:10.1016/j.bpj.2013.05.045.

    Google Scholar 

  • Tweten RK. Clostridium perfringens beta toxin and Clostridium septicum alpha toxin: their mechanisms and possible role in pathogenesis. Vet Microbiol. 2001;82:1–9.

    Article  CAS  PubMed  Google Scholar 

  • Uzal FA, Kelly WR. Effects of the intravenous administration of Clostridium perfringens type D epsilon toxin on young goats and lambs. J Comp Pathol. 1997;116(1):63–71.

    Article  CAS  PubMed  Google Scholar 

  • Uzal FA, Glastonbury JR, Kelly WR, Thomas R. Caprine enterotoxaemia associated with cerebral microangiopathy. Vet Rec. 1997;141(9):224–6.

    Article  CAS  PubMed  Google Scholar 

  • Uzal FA, Kelly WR, Morris WE, Bermudez J, Baison M. The pathology of peracute experimental Clostridium perfringens type D enterotoxemia in sheep. J Vet Diagn Invest. 2004;16(5):403–11.

    Article  CAS  PubMed  Google Scholar 

  • Wioland L, Dupont JL, Bossu JL, Popoff MR, Poulain B. Attack of the nervous system by Clostridium perfringens Epsilon toxin: from disease to mode of action on neural cells. Toxicon. 2013;75:122–35.

    Article  CAS  PubMed  Google Scholar 

  • Wioland L, Dupont JL, Doussau F, Gaillard S, Heid F, Isope P, Pauillac S, Popoff MR, Bossu JL, Poulain B. Epsilon toxin from Clostridium perfringens acts on oligodendrocytes without forming pores, and causes demyelination. Cell Microbiol. 2015;17(3):369–88.

    Article  CAS  PubMed  Google Scholar 

  • Zhu C, Ghabriel MN, Blumbergs PC, Reilly PL, Manavis J, Youssef J, Hatami S, Finnie JW. Clostridium perfringens prototoxin-induced alteration of endothelial barrier antigen (EBA) immunoreactivity at the blood-brain barrier (BBB). Exp Neurol. 2001;169(1):72–82.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michel R. Popoff .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Dordrecht

About this entry

Cite this entry

Popoff, M.R., Stiles, B., Poulain, B. (2016). Clostridium perfringens Epsilon Toxin: Structural and Mechanistic Insights. In: Gopalakrishnakone, P., Stiles, B., Alape-Girón, A., Dubreuil, J., Mandal, M. (eds) Microbial Toxins. Toxinology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6725-6_9-1

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-6725-6_9-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Online ISBN: 978-94-007-6725-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics